NPF Primer: GLP-1s Worth Considering as Adjunct for Select Psoriasis Patients

Published by

www.medpagetoday.com

on •1 min read

(MedPage Today) -- GLP-1 receptor agonists represent a "biologically plausible and clinically intriguing adjunct" to psoriasis therapy for selected patients, authors of a National Psoriasis Foundation (NPF) "primer" concluded.

Learn more